Lung

Lung
2025-05-14T00:00:00.000+10:00
Ongoing

NVL-330-01

NVL-330-01
Non-small cell lung cancer (NSCLC)

A Phase 1a/1b Study of the Selective Tyrosine Kinase Inhibitor NVL-330 in Patients with Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

A Phase 1a/1b Study of the Selective Tyrosine Kinase Inhibitor NVL-330 in Patients with Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Trial overview

Clinical Area

Medical Oncology

Disease

Non-small cell lung cancer (NSCLC)

Disease site

Lung & bronchus

Study Phase

I

Trial Identifiers

Registration number: NCT06521554

https://clinicaltrials.gov/study/NCT06521554

GenesisCare Location(s)
Principal Investigator(s)
Medical Oncologist

Prof. Nick Pavlakis

BSc MBBS MMed PhD FRACP

Prof. Nick Pavlakis
location pin icon

Frenchs Forest (Oncology) +1

View Profile
Profile Image - Prof. Nick Pavlakis

Clinical trials enquiries

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.